Proliferation and anti-apoptotic effects of human urotensin II on human endothelial cells

Atherosclerosis

Volumn 188, Issue 2, 2006, Pages 260-264

  Shi, Libin ^a   Ding, Wenghui ^a   Li, Dayuan ^b   Wang, Zhijian ^a   Jiang, Hongfeng ^c   Zhang, Junhua ^a   Tang, Chaoshu ^c  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c PEKING UNIVERSITY   (China)

Author keywords

Apoptosis; Endothelial cells; Human urotensin II; Proliferation; Protein kinases

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; THYMIDINE; TUMOR NECROSIS FACTOR ALPHA; UROTENSIN II;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INCUBATION TIME; NICK END LABELING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL PROLIFERATION; DNA REPLICATION; ENDOTHELIAL CELLS; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; MITOGEN-ACTIVATED PROTEIN KINASE 1; PHOSPHORYLATION; SIGNAL TRANSDUCTION; UMBILICAL CORD; UROTENSINS;

EID: 33748195575     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.10.044     Document Type: Article

References (21)

1. Ames R.S., Sarau H.M., Chambers J.K., et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401 (1999) 282-286
2. Matsushita M., Shichiri M., Imai T., et al. Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J Hypertens 19 (2001) 2185-2190
3. Zhu Y.Z., Wang Z.J., Zhu Y.C., et al. Urotensin II causes fatal circulatory collapse in anaesthesized cynomolgus monkeys in vivo: a 'vasoconstrictor' with a unique hemodynamic profile. Am J Physiol Heart Circ Physiol 286 (2004) H830-H836
4. Tzanidis A., Hannan R.D., Thomas W.G., et al. Henry Krum direct actions of urotensin II on the heart. Implications for cardiac fibrosis and hypertrophy. Circ Res 93 (2003) 246
5. Wang H., Mehta J.L., Chen K., Zhang X., and Li D. Human urotensin II modulates collagen synthesis and the expression of MMP-1 in human endothelial cells. J Cardiovasc Pharmacol 44 (2004) 577-581
6. Stirrat A., Gallagher M., Douglas S.A., et al. Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries. Am J Physiol Heart Circ Physiol 280 (2001) H925-H928
7. Chen Y., Zhao M., Liu X., Yao W., Yang J., Zhang Z., et al. Urotensin II receptor in the rat airway smooth muscle and its effect on the rat airway smooth muscle cells proliferation. Chin Med Sci J 16 (2001) 231-235
8. Li D.Y., Chen H.J., Staples E.D., et al. Oxidized low-density lipoprotein receptor LOX-1 and apoptosis in human atherosclerotic lesions. J Cardiovasc Pharmacol Ther 7 (2002) 147-153
9. Chen J., Mehta J.L., Haider N., et al. Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells. Circ Res 94 (2004) 370-376
10. Chen H., Li D., Sawamura T., Inoue K., and Mehta J.L. Upregulation of LOX-1 expression in aorta of hypercholesterolemic rabbits: modulation by losartan. Biochem Biophys Res Commun 276 (2000) 1100-1104
11. Khan A., Moe G.W., Nili N., et al. The cardiac atria are chambers of active remodeling and dynamic collagen turnover during evolving heart failure. J Am Coll Cardiol 43 (2004) 68-76
12. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 79 (1999) 215-262
13. Weber K.T., Sun Y., and Guarda E. Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension 23 (1994) 869-877
14. Patella V., Marino I., Arbustini E., et al. Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 97 (1998) 971-978
15. Engels W., Reiters P.H., Daemen M.J., Smits J.F., and van der Vusse G.J. Transmural changes in mast cell density in rat heart after infarct induction in vivo. J Pathol 177 (1995) 423-429
16. Hara M., Ono K., Hwang M.W., et al. Evidence for a role of mast cells in the evolution to congestive heart failure. J Exp Med 195 (2002) 375-381
17. Watanabe T., Pakala R., Katagiri T., et al. Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation. J Hypertens 19 (2001) 2191-2196
18. Watanabe T., Pakala R., Katagiri T., and Benedict C.R. Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells. Circulation 104 (2001) 16-18
19. Douglas S.A., Tayara L., Ohlstein E.H., Halawa N., and Giaid A. Congestive heart failure and expression of myocardial urotensin II. Lancet 359 (2002) 1990-1997
20. Nothacker H.P., Wang Z., McNeill A.M., et al. Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction. Nat Cell Biol 1 (1999) 383-385
21. Tamura K., Okazaki M., Tamura M., et al. II-induced activation of extracellular signal-regulated kinase in cultured vascular smooth muscle cells: involvement of cell adhesion-mediated integrin signaling. Life Sci 72 (2003) 1049-1060